Shunsuke Ebara

Synergistic apoptotic effects in cancer cells by the combination of CLK and Bcl-2 family inhibitors

S. Sasaki, T. Miyazaki, T. Ohashi, 2020, PloS one.

CDK8/19 inhibition induces premature G1/S transition and ATR-dependent cell death in prostate cancer cells

A. Nakamura, A. Hata, T. Hara, 2018, Oncotarget.

Inhibition of malic enzyme 1 disrupts cellular metabolism and leads to vulnerability in cancer cells in glucose-restricted conditions

A. Ando, T. Hara, Y. Satomi, 2017, Oncogenesis.

Succinate dehydrogenase B-deficient cancer cells are highly sensitive to bromodomain and extra-terminal inhibitors

T. Soga, A. Ando, T. Hara, 2017, Oncotarget.

Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response

R. Nishigaki, A. Ando, A. Nakamura, 2018, Proceedings of the National Academy of Sciences.

Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitor

K. Burke, Jie Yu, T. Miyazaki, 2019, Science Advances.